Regeneron Pharmaceuticals, Inc. (REGN) Financials

REGN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 41.7 billion 10.0 billion
March 31, 2026 40.9 billion 9.4 billion
Dec. 31, 2025 40.6 billion 9.3 billion
Sept. 30, 2025 40.2 billion 9.2 billion

REGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 334.3 million 243.0 million
March 31, 2026 848.3 million 257.4 million
Dec. 31, 2025 922.0 million 249.3 million
Sept. 30, 2025 1.4 billion 237.0 million

REGN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 1.3 billion
March 31, 2026 727.2 million
Dec. 31, 2025 844.6 million
Sept. 30, 2025 1.5 billion

REGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 8.0 billion 2.0 billion 720.0 million
March 31, 2026 8.8 billion 2.0 billion 720.0 million
Dec. 31, 2025 8.6 billion 2.0 billion 720.0 million
Sept. 30, 2025 8.4 billion 2.0 billion 720.0 million

REGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 106.8 million
March 31, 2026 107.7 million
Dec. 31, 2025 107.5 million
Sept. 30, 2025 107.2 million

REGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 240.2 million 1.6 billion 662.1 million -
March 31, 2026 230.6 million 1.6 billion 647.7 million -
Dec. 31, 2025 248.7 million 1.6 billion 775.0 million -
Sept. 30, 2025 201.4 million 1.6 billion 657.8 million -

REGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 4.3 billion 576.5 million
March 31, 2026 3.6 billion 669.4 million
Dec. 31, 2025 3.9 billion 584.6 million
Sept. 30, 2025 3.8 billion 521.6 million

REGN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

REGN

Price: $799.08

52 week price:
538.87
840.84

Dividend Yield: 0.48%

5-year range yield:
0.48%
0.63%

Forward Dividend Yield: 0.47%

Payout Ratio Range:
1.95%
425.53%

Dividend Per Share: 3.76 USD

Earnings Per Share: 40.47 USD

P/E Ratio: 18.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 417600

Ebitda: 597.4 million

Market Capitalization: 78.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 2

Links: